Advocate Medical Group
Naperville, Illinois, United States
General hospital in Naperville, Illinois
100 Spalding Dr, Naperville, IL 60540
About Advocate Medical Group
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Advocate Medical Group
During the past decade, Advocate Medical Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery
2015-11-06
2029-01-01
Recruiting
126
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
2017-01-13
2023-10-31
Active, not recruiting
818
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2017-05-12
2023-06-30
Active, not recruiting
444
Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes
2017-09-29
2022-04-15
Terminated
23
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
2017-12-22
2023-08-01
Active, not recruiting
1,670
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
2017-06-01
2024-08-01
Suspended
310
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery
2017-04-13
2023-11-30
Suspended
175
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Advocate Medical Group
According to Clinical.Site data, the most researched conditions in "Advocate Medical Group" are
"Heart Failure" (2 trials), "Artery Disease, Peripheral" (1 trials), "Contrast Induced Nephropathy" (1 trials), "Femoropopliteal Artery Occlusion" (1 trials) and "Peripheral Arterial Disease" (1 trials). Many other conditions were trialed in "Advocate Medical Group" in a lesser frequency.
Clinical Trials Intervention Types at Advocate Medical Group
Most popular intervention types in "Advocate Medical Group" are "Device" (4 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "BAROSTIM NEO® System" (2 trials), "Medical Management" (1 trials), "Medtronic IN.PACT Admiral DCB" (1 trials), "RenalGuard Therapy" (1 trials) and "Standard Therapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Advocate Medical Group
The vast majority of trials in "Advocate Medical Group" are
4 trials for "All" genders.
Clinical Trials Status at Advocate Medical Group
Currently, there are NaN active trials in "Advocate Medical Group".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Advocate Medical Group,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Advocate Medical Group, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".